Hepatitis B and Adoption

3 05 2010

Adoption is fun but scary, and full of love and uncertainty—even when the process goes perfectly.

Sometimes, during the adoption process, the parents-to-be get news that makes them pause, and they wish they could gaze into a crystal ball to see the outcome of each decision they have to make, especially if the news is that the child with whom they’re matched is infected with the hepatitis B virus (HBV).

As you work through your decisions, here are some thoughts for you to consider from PKIDs parents who’ve adopted HBV+ children:

First, ask your healthcare provider about the HBV vaccine. You should be protected against this virus, even if you don’t end up adopting a child who is HBV+.

For persons in developed countries who are adopting domestically and have identified the birth mother, ensure that the birth mother is screened for, among other infections, hepatitis B. If the birth mother is positive for HBV, make sure the baby is vaccinated against hepatitis B and receives hepatitis B immunoglobin (HBIG) within 12 hours of birth. This helps to prevent transmission of the virus to the newborn.

Although this protocol is usually effective, you will not know for sure if the baby is infected until the baby is screened for HBV 1or 2 months after completing the three-shot hepatitis B vaccine series (at least 9 months after birth).

In some countries, the tests for HBV infection may not be reliable or may not be interpreted correctly, and it’s possible the child was never tested for HBV infection, although the paperwork may say otherwise.

If you’re adopting internationally, you won’t know for sure about your child’s HBV status until you get the child home and have him or her screened for the virus.

As you consider whether or not HBV is a disease for which you’re prepared, you can learn more about the infection and treatment options for children in PKIDs’ Pediatric Hepatitis Report. The Hepatitis B Foundation also has lots of information.

Search the Internet for articles and studies specific to HBV infection in children.  Keep in mind that treatment options for children are different than those for adults, so not all of the information you find will apply to kids.

Join and post on PKIDs’ listserv and the HBV_adoption listserv to interact with families living with HBV.

Be aware that there is a stigma associated with HBV.  At PKIDs, many families have experienced severe problems within their own extended families after disclosing, as well as problems at school and among friends and colleagues.  Should you decide to adopt an HBV+ child, you need to be aware of this so that you can determine to whom you will disclose your child’s medical information. You can always choose to disclose at a later time, but you can never take that information back, once it is out.

Your child’s lab results from his or her birth country may not give you the status of your child’s HBV infection.  Test results are often outdated, lacking, or inaccurate, and at best provide a snapshot at the time of the test.  It’s unwise to base your adoption decision on international lab work, and you should not request additional testing.  HBV is readily spread by needle re-use, which is problematic in many countries. You actually put the child at risk by requesting more lab work, which will be re-done anyway when your child arrives home.

It’s impossible to say when or if a child will need treatment.  No two HBV infections are the same. At a minimum, and even if the child is asymptomatic, there will be regular lab work that needs to be done.

All of this is manageable, and daily life with a child with HBV is typically very normal.  However, there are kids who need treatment and for whom the infection is serious.

Most people infected as babies who then go on to develop a chronic or lifelong infection go decades without needing treatment, and many live a long, healthy life and die of old age.

Others need treatment while they’re still kids.

There is no true cure for HBV infection, and those infected at birth are at increased risk for advanced liver disease or liver cancer before they are 30 years old.

A lot to think about, but we hope we’ve given you some tools to use as you determine what’s right for you.

Share





New HCV Drug: Will it work in humans?

18 12 2009

Recently, a new drug, SPC3649, was administered by IV to four HCV-infected chimpanzees over a period of twelve weeks.

Rather than targeting the actual virus, this drug targets a molecule that is found naturally in the liver. The hepatitis C virus uses this molecule to replicate and multiply. The SPC3649 drug attempts to inhibit the molecule to prevent replication of the virus.

In the chimpanzees, the hepatitis C viral load was dramatically reduced in those that received the highest dose. Additionally, the virus did not appear to develop any resistance to the SPC3649 drug.

Trials for SPC3649 in humans with healthy livers are currently in process. Trials for people with hepatitis C will likely start in 2010.

Share





Hepatitis A. Are you (and yours) protected?

21 09 2009

Stock PhotoSome parents feel the hepatitis A vaccine is one their child can skip.  Children infected with the hepatitis A virus (HAV) often have symptoms so mild they aren’t even noticeable.  Do they really need the shot?

We think so, and here’s why.

Let’s say Macey is a second-grader who’s not immunized against HAV.  Consequently, she gets infected from tainted salad at a local restaurant.

Having no symptoms, Macey goes to school and exposes classmates to HAV through lack of proper handwashing in the restroom.  (Those who do experience symptoms may get a fever, nausea, diarrhea, and severe stomach pains for up to a month.)

If anyone in her life has chronic hepatitis B or C, and is not immunized against HAV, they’re at risk of fatal consequences.  People with compromised immune systems and other liver diseases are also at risk.

If Macey doesn’t get the hepatitis A vaccine and does not get the disease as a child, she’s at risk of contracting the disease later.  Adults infected with HAV generally experience more severe symptoms.  One in five people infected with hepatitis A require hospitalization, and some are sick for up to six months.

In 2003, an outbreak at a restaurant in Pennsylvania sickened 660 people and killed four. The disease may be mild, but it’s no party.

Parents should check with their providers to see if vaccination is right for their family.

Share





NVHR

9 06 2009

The National Viral Hepatitis Roundtable (NVHR) is a coalition working to eliminate viral hepatitis in the U.S.

nvhr-logo09

They have a Call to Action that, when implemented, will save lives by preventing infection.

Hepatitis B and C can cause cancer or even death in children and adults.

Join with the NVHR in asking that funds be put toward the elimination of these deadly diseases.

Share





Hep B Foundation Conference

15 05 2009

The Hepatitis B Foundation is having its annual B Informed Patient Conference.  We want folks to know about it, so here’s the info from their website and for registration details, click here:

hep b fdn

 

 

 

 

 

The 2009 B Informed Patient Conference, sponsored by the Hepatitis B Foundation in partnership with the Hepatitis B Information and Support List (HB-L), will be held June 26-27 at Delaware Valley College, Doylestown, Pennsylvania, just a few miles from the home of the Hepatitis B Foundation.

Highlights of this year’s conference will include formal presentations by clinical and research experts with interactive Q & A sessions.

The keynote address will be given by Dr. Mack Mitchell, Director, Division of Gastroenterology and Digestive Diseases at Johns Hopkins Bayview Medical Center, will provide an update on the care and treatment of chronic hepatitis B in adults.

An update for children with chronic hepatitis B will be given by Dr. Barbara Haber, Children’s Hospital of Philadelphia.

Information about the new NIH HBV Clinical Research Network will be given by hepatologist Dr. Michael Fried, U. of North Carolina; an update on hepatitis B and liver cancer by Dr. Kenneth Rothstein, Drexel U. Liver Center; and the hepatitis B drug watch by Dr. Timothy Block, president of the Hepatitis B Foundation and professor at Drexel University College of Medicine.





Hepatitis B Vaccine Birth Dose

12 05 2009

Hepatitis B virus (HBV) infection has the reputation of being a sexually transmitted disease.  That’s because it is an STD.  But, it’s also a virus that can pass from a mom to her newborn at or soon after birth.

Pregnant women can become infected with HBV and not know it, then pass it on to their newborns. OBs will test at-risk women early in the pregnancy and again at birth, but what if you’re not considered at-risk and you get infected? 

Giving a newborn the birth dose of the HBV vaccine is important because if a newborn becomes infected with hepatitis B, that baby has a 90 percent chance of staying infected – being chronically infected – for life.

This infection may never cause any harm, but it could cause liver damage, liver cancer or even death. 

Treatment options are not great and, because there is a vaccine for HBV, not a lot of money gets put into this research.  They’re not even searching for a cure, just possible ways to stop the damage caused by the viral infection.

Get vaccinated.  Get your babies and children vaccinated.  Hepatitis B is around and no one can say how it will act in any one body.  Why take the chance?





7th Annual Hepatitis B Foundation Patient Conference

10 04 2007

Maureen Kamischke reveals the highlights of the upcoming Hep B Foundation conference. For more information, visit www.pkids.org or www.hepb.org.

Listen now!

Right-click here to download podcast (8 min, 3.5 MB)





Interview with Dr. Tim Block of the Hepatitis B Foundation

31 03 2007

PKIDs interviews Dr. Tim Block of the Hepatitis B Foundation. For more information, visit www.pkids.org or www.hepb.org.

Listen now!

Right-click here to download podcast (44 min, 17.5 MB)





HBF Patient Conference

21 03 2007

THE SEVENTH ANNUAL B INFORMED PATIENT CONFERENCE!
 
Sponsored by the Hepatitis B Foundation (HBF) will be held June 8 – 9, 2007, at Thomas Jefferson University, Philadelphia, PA.
 
This year the Patient Conference will include a special session for parents of children with Hepatitis B on the afternoon of Friday, June 8th!
 
The featured speaker for the parent session is Dr. Maureen Jonas, of Children’s Hospital,  Boston.  Dr. Jonas is a renowned pediatric hepatologist.  Her research focuses on liver disease in children with emphasis on viral hepatitis.
 
Topics such as What should I know about Hepatitis BWho to tell, and What to tell my child will be discussed.  Disclosure topics will be discussed with Augie Acevedo, LMSW.  All discussions will be moderated by Chris Kukka and Maureen Kamischke
 
Saturday will include a day filled with expert guest speakers, doctors and researchers, including author and liver disease specialist, Dr. Melissa Palmer. 
 
Workshop sessions will be offered in topics such as:  Hepatitis B Basics, Talking to Friends, Family and Lovers, Alternative and Complementary Therapies and a session on Children and HBV run by Maureen Kamischke and Chris Kukka. 
 
This is a great opportunity for parents of children with hepatitis B to meet face-to-face to discuss topics with both experts and friends. 
 
Register online today:
http://www.hepb.org/patients/patient_conference2007.htm
 
Make Your Hotel Reservations Before May 8.
Special conference rates of $99/room have been reserved a the Philadelphia Holiday Inn for the Hepatitis B Patient Conference.  Call 215-735-9300 before May 8th to reserve!
 
For more information, please contact:
Ms. Peggy Farley
peggy@hepb.org
 
Visit the HBF website at www.hepb.org for a complete agenda listing.

 





Sweat and HBV

9 03 2007

Study of wrestlers suggests vaccinating Olympians against the disease

A recent article from Reuters reported that “findings from a study of Olympic wrestlers indicate that hepatitis B virus is found in the sweat of infected individuals, and so sweating might be a way that the virus could be passed between participants in contact sports.”

We all know that HBV is transmitted through blood and other body fluids, but sweat was never considered a viable route of transmission.  This is the first study that has looked at the possibility of sweat carrying the virus and it found HBV DNA in the sweat of some HBV+ study participants.

Researchers concluded that “evidence is emerging that the incidence of occult HBV in Olympic wrestling is higher than expected and that transmission of HBV may also occur through sweat.”

Recommendations from the study are that sports organizations make it “obligatory for all participants involved in contact sports and playing under adult rules to be vaccinated against hepatitis B.”








Follow

Get every new post delivered to your Inbox.